Oramed (ORMP) to Conduct Sub-Study on Oral Insulin per FDA Request
Go back to Oramed (ORMP) to Conduct Sub-Study on Oral Insulin per FDA Request| ORAMED (NASDAQ: ORMP) | Delayed: 4.48 +0.10 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.38 | 52 Week High | $10.74 | |||
| Open | $4.30 | 52 Week Low | $5.60 | |||
| Day High | $4.53 | P/E | N/A | |||
| Day Low | $4.30 | EPS | $-0.59 | |||
| Volume | 156,769 | |||||

